Biomedical Department, Centre Scientifique de Monaco, Monaco, Monaco
Charlotte Hinault
Université Côte d’Azur, Inserm, C3M, Team Targeting prostate cancer cell metabolism, Nice, France; Biochemistry Laboratory, University Hospital, Nice, France
Laurent Bonesso
Biochemistry Laboratory, University Hospital, Nice, France
MRC Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial CollegeLondon, London, United Kingdom
Jennifer Uhler
Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden
Marie Irondelle
Inserm U1065, Université Côte d’Azur, Nice, France
Anne-sophie Gay
Université Côte d'Azur, CNRS, IPMC, Valbonne, France
Lucile Fleuriot
Université Côte d'Azur, CNRS, IPMC, Valbonne, France
To adapt in an ever-changing environment, cells must integrate physical and chemical signals and translate them into biological meaningful information through complex signaling pathways. By combining lipidomic and proteomic approaches with functional analysis, we have shown that ubiquitin domain-containing protein 1 (UBTD1) plays a crucial role in both the epidermal growth factor receptor (EGFR) self-phosphorylation and its lysosomal degradation. On the one hand, by modulating the cellular level of ceramides through N-acylsphingosine amidohydrolase 1 (ASAH1) ubiquitination, UBTD1 controls the ligand-independent phosphorylation of EGFR. On the other hand, UBTD1, via the ubiquitination of Sequestosome 1 (SQSTM1/p62) by RNF26 and endolysosome positioning, participates in the lysosomal degradation of EGFR. The coordination of these two ubiquitin-dependent processes contributes to the control of the duration of the EGFR signal. Moreover, we showed that UBTD1 depletion exacerbates EGFR signaling and induces cell proliferation emphasizing a hitherto unknown function of UBTD1 in EGFR-driven human cell proliferation.